Ph. Eur. 3.2.9: Rubber Closures for Aqueous Parenteral Preparations

European Pharmacopoeia general chapter 3.2.9 sets out the requirements for rubber closures used to seal containers of aqueous parenteral preparations, powders, and freeze-dried powders. Its full title is “Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders.” It is published by the European Directorate for the Quality of Medicines and HealthCare (EDQM) and applies to the elastomeric closures (rubber stoppers) that seat in the vial and hold the sterile product. For any medicine sold in the European market, the closure must meet this chapter, which is why EU-export buyers ask suppliers about it.

This guide explains what Ph. Eur. 3.2.9 covers, how it classifies and tests rubber closures, how it relates to the aluminium seal that crimps over the closure, and how it compares with the equivalent USP chapters.

Key takeaways

Ph. Eur. 3.2.9 sets the requirements for rubber closures for aqueous parenteral preparations, powders, and freeze-dried powders. It governs the elastomeric stopper, not the metal seal on top of it.
It is a European Pharmacopoeia general chapter, published by the EDQM, and it is legally binding in the EU because the general monographs on Pharmaceutical preparations (2619) and Parenteral preparations (0520) refer to it.
The revised chapter was published in Ph. Eur. Supplement 11.1 with an implementation date of 1 April 2023, adding provisions for coated closures, bi-layer seals, and lubricated closures.
It sets identification, physical, and chemical requirements, including tests on the aqueous extract (for example appearance, acidity or alkalinity, absorbance, reducing substances, and extractable metals).
Natural rubber latex is not permitted; dry natural rubber may be used because the allergens are removed during processing.
It is the European counterpart to the USP chapters on elastomeric components, USP <381> and USP <382>.

What is Ph. Eur. 3.2.9?

Ph. Eur. 3.2.9 is the European Pharmacopoeia general chapter that specifies the material requirements and test methods for rubber (elastomeric) closures used with injectable containers. It is published by the European Directorate for the Quality of Medicines and HealthCare (EDQM), the body that maintains the European Pharmacopoeia.

A rubber closure is the stopper that seats in the vial neck and forms the primary seal against the drug; the aluminium or aluminium-plastic seal is then crimped over it to hold it compressed. Because the closure is in direct and prolonged contact with a sterile injectable, it must not release harmful substances, must reseal after needle penetration, and must be compatible with the product. Ph. Eur. 3.2.9 defines the requirements the closure material must meet and the tests used to demonstrate them. The chapter is mandatory for aqueous parenteral preparations in the EU because it is cross-referenced by legally binding general monographs, so it functions as a compliance requirement, not just guidance.

What Ph. Eur. 3.2.9 requires

Ph. Eur. 3.2.9 requires rubber closures to pass identification, physical, and chemical tests, most of them run on an aqueous extract of the closures. The closures are manufactured by vulcanising (cross-linking) elastomers with suitable additives, and the chapter tests what those materials release and how the closure behaves. In broad terms it covers:

Identification. Confirming the elastomer type by methods such as infrared spectroscopy or thermal analysis.
Chemical tests on the aqueous extract. Tests including the appearance of the solution, acidity or alkalinity, absorbance in the ultraviolet and visible range, reducing substances, and extractable metals such as zinc, so the closure does not contaminate the product.
Physical and functional tests. Requirements relevant to how the closure performs in use, including penetrability, fragmentation, and self-sealing after needle penetration, so the seal holds and coring is controlled.
Material restrictions. Natural rubber latex is not permitted; dry natural rubber may be used because its allergenic proteins are removed during processing.

The revised chapter, effective 1 April 2023, extended these provisions to modern closure constructions such as coated closures, bi-layer seals, and lubricated closures. A closure that meets Ph. Eur. 3.2.9 has been shown to be chemically clean and functionally sound for sealing an injectable.

How 3.2.9 relates to the aluminium seal

Ph. Eur. 3.2.9 governs the rubber closure; the aluminium or aluminium-plastic seal that crimps over it is a separate component with its own material and dimensional requirements. In a vial closure system three parts work together: the glass vial, the rubber stopper, and the metal seal. The stopper forms the seal against the drug and is what 3.2.9 controls. The aluminium seal then crimps under the vial neck flange to hold the stopper compressed, maintaining the container closure integrity of the pack. The seal’s own conformity comes from its aluminium and plastic material specifications and its dimensioning to the vial neck, covered by the ISO 8362 series and the applicable food-contact and pharmacopoeial material standards. The two components are qualified separately but must be compatible, since the seal has to keep the 3.2.9-compliant closure correctly seated for the life of the product.

Ph. Eur. 3.2.9 vs the USP chapters

Ph. Eur. 3.2.9 is the European requirement for rubber closures; USP <381> and USP <382> are the corresponding United States chapters. They pursue the same goal, a clean and functional elastomeric closure, through comparable but not identical tests, so a closure is often characterised against both for products sold in multiple markets.

Region	Chapter	Scope
Europe	Ph. Eur. 3.2.9	Rubber closures for aqueous parenteral preparations, powders, and freeze-dried powders
United States	USP <381>	Elastomeric closures for injections (physicochemical and functional tests)
United States	USP <382>	Elastomeric closure functional suitability

A drug maker exporting to both regions typically qualifies its stopper against Ph. Eur. 3.2.9 and the USP chapters, and separately qualifies the aluminium seal that crimps over it. For related detail, see elastomeric closures in the wider container closure context.

How this works in practice at Autofits

Ph. Eur. 3.2.9 governs the rubber stopper, so it applies to the closure maker rather than to Autofits, which manufactures the aluminium and aluminium-plastic seals that crimp over the stopper. Autofits supports its customers’ EU-export needs by supplying seals that are dimensionally matched to standard vial necks and made from controlled materials: AA8011 aluminium alloy, epoxy lacquer conforming to 21 CFR 175.300, and polypropylene conforming to 21 CFR 177.1520, with heavy metals held to a maximum 100 ppm total and BSE/TSE-free status. The FlipTop Optima flip-off seals, tear-off and tear-down aluminium seals, and aluminium pilfer-proof (ROPP) caps are produced under an ISO 15378:2017 quality system, alongside ISO 9001:2015 and ISO 14001:2015 certification, a Drug Master File (DMF 18100), and CFDA registration (B20200000501), in a 75,000 sq ft facility in Nashik, India, with an ISO Class 8 cleanroom and high-speed visual inspection. A seal that keeps a 3.2.9-compliant stopper correctly seated is what preserves the pack’s integrity.

Frequently asked questions

What does Ph. Eur. 3.2.9 cover?

Ph. Eur. 3.2.9 sets the material requirements and test methods for rubber (elastomeric) closures used to seal containers of aqueous parenteral preparations, powders, and freeze-dried powders. It covers identification, chemical tests on an aqueous extract, and physical or functional tests such as penetrability, fragmentation, and self-sealing. It governs the rubber stopper, not the metal seal crimped over it.

Is Ph. Eur. 3.2.9 mandatory?

Yes, for aqueous parenteral preparations in the European market. The chapter is cross-referenced by the legally binding general monographs on Pharmaceutical preparations (2619) and Parenteral preparations (0520), which makes compliance a requirement rather than guidance. Confirm current text and applicability with the EDQM.

When was Ph. Eur. 3.2.9 last revised?

The revised chapter was published in Ph. Eur. Supplement 11.1 with an implementation date of 1 April 2023. The revision added provisions for coated closures, bi-layer seals, and lubricated closures, and confirmed that natural rubber latex is not permitted while dry natural rubber may be used.

How does Ph. Eur. 3.2.9 compare with USP <381> and <382>?

Ph. Eur. 3.2.9 is the European requirement for rubber closures; USP <381> and USP <382> are the corresponding United States chapters on elastomeric closures. They aim at the same outcome through comparable but not identical tests, so a closure sold in both markets is usually characterised against both.

Does Ph. Eur. 3.2.9 apply to the aluminium seal?

No. Ph. Eur. 3.2.9 applies to the rubber closure. The aluminium or aluminium-plastic seal crimped over the closure is a separate component, qualified through its own material specifications and its dimensioning to the vial neck. The two components must be compatible so the seal keeps the compliant closure correctly seated.

Sources

EDQM: Revised general chapter on rubber closures published in the Ph. Eur. Supplement 11.1 (https://www.edqm.eu/en/-/revised-general-chapter-on-rubber-closures-published-in-the-ph.-eur.-supplement-11.1)
European Pharmacopoeia: general chapter 3.2.9, Rubber closures for containers for aqueous parenteral preparations, for powders and for freeze-dried powders (https://www.edqm.eu/en/european-pharmacopoeia)
USP-NF: General Chapters <381> and <382>, Elastomeric Closures for Injections (https://www.usp.org/)

“`json { “@context”: “https://schema.org”, “@graph”: [ { “@type”: “Article”, “headline”: “Ph. Eur. 3.2.9: Rubber Closures for Aqueous Parenteral Preparations”, “description”: “European Pharmacopoeia general chapter 3.2.9 sets the material requirements and test methods for rubber closures used with aqueous parenteral preparations, powders, and freeze-dried powders.”, “author”: {“@type”: “Organization”, “name”: “Autofits Technical Team”}, “publisher”: { “@type”: “Organization”, “name”: “Autofits Packaging Pvt. Ltd.”, “address”: { “@type”: “PostalAddress”, “streetAddress”: “E-13/7/4, MIDC, Malegaon, Sinnar”, “addressLocality”: “Nashik”, “addressCountry”: “IN” } }, “datePublished”: “2026-07-06”, “dateModified”: “2026-07-06” }, { “@type”: “FAQPage”, “mainEntity”: [ {“@type”: “Question”, “name”: “What does Ph. Eur. 3.2.9 cover?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Ph. Eur. 3.2.9 sets the material requirements and test methods for rubber (elastomeric) closures used to seal containers of aqueous parenteral preparations, powders, and freeze-dried powders. It covers identification, chemical tests on an aqueous extract, and physical or functional tests such as penetrability, fragmentation, and self-sealing. It governs the rubber stopper, not the metal seal crimped over it.”}}, {“@type”: “Question”, “name”: “Is Ph. Eur. 3.2.9 mandatory?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Yes, for aqueous parenteral preparations in the European market. The chapter is cross-referenced by the legally binding general monographs on Pharmaceutical preparations (2619) and Parenteral preparations (0520), which makes compliance a requirement rather than guidance. Confirm current text and applicability with the EDQM.”}}, {“@type”: “Question”, “name”: “When was Ph. Eur. 3.2.9 last revised?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “The revised chapter was published in Ph. Eur. Supplement 11.1 with an implementation date of 1 April 2023. The revision added provisions for coated closures, bi-layer seals, and lubricated closures, and confirmed that natural rubber latex is not permitted while dry natural rubber may be used.”}}, {“@type”: “Question”, “name”: “How does Ph. Eur. 3.2.9 compare with USP <381> and <382>?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “Ph. Eur. 3.2.9 is the European requirement for rubber closures; USP <381> and USP <382> are the corresponding United States chapters on elastomeric closures. They aim at the same outcome through comparable but not identical tests, so a closure sold in both markets is usually characterised against both.”}}, {“@type”: “Question”, “name”: “Does Ph. Eur. 3.2.9 apply to the aluminium seal?”, “acceptedAnswer”: {“@type”: “Answer”, “text”: “No. Ph. Eur. 3.2.9 applies to the rubber closure. The aluminium or aluminium-plastic seal crimped over the closure is a separate component, qualified through its own material specifications and its dimensioning to the vial neck. The two components must be compatible so the seal keeps the compliant closure correctly seated.”}} ] }, { “@type”: “BreadcrumbList”, “itemListElement”: [ {“@type”: “ListItem”, “position”: 1, “name”: “Standards”, “item”: “/standards/”}, {“@type”: “ListItem”, “position”: 2, “name”: “Ph. Eur. 3.2.9”, “item”: “/standards/ep-3-2-9/”} ] } ] } “`

*Last updated: 2026-07-06. This article is general regulatory information, not legal or compliance advice; confirm current regulatory text and requirements with the EDQM and the European Pharmacopoeia.*